Related Experiment Videos
Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids
M Neudorfer1, O Merimsky, M Lazar
1Department of Ophthalmology, Ichilov Hospital, Tel Aviv, Israel.
Annals of Ophthalmology
|January 1, 1993
Abstract:
Cisplatin and doxorubicin were used in the treatment of recurrent invasive basal cell carcinoma (BCC) of the medial canthus and orbit. Complete remission was observed after treatment termination, and this was still evident five years later. Systemic chemotherapy offers an alternative mode of treatment for selected cases of advanced BCC.